IASO Appoints Dr. Biao Zheng as Chief Scientific Officer and Dr. Wen Wang as Chief Medical Officer

IASO BIO, a clinical-stage company focused on developing and commercializing novel cellular immunotherapy to treat cancer, is pleasant to announce the appointment of Dr. Biao Zheng as Chief Scientific Officer (CSO), and the appointment of Dr. Wen Wang as Chief Medical Officer (CMO).

IASO Bio to Present at ASH 2019

IASO Bio to Present at IMWG 2019

IASO Bio to Present at EHA

IASO Bio to Present at ASCO 2019

IASO Bio to Present at Global Summit on Hematologic Malignancies